These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 23515914)
21. Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner. Yan B; Stantic M; Zobalova R; Bezawork-Geleta A; Stapelberg M; Stursa J; Prokopova K; Dong L; Neuzil J BMC Cancer; 2015 May; 15():401. PubMed ID: 25967547 [TBL] [Abstract][Full Text] [Related]
22. Comparison of mammosphere formation from stem-like cells of normal breast, malignant primary breast tumors, and MCF-7 cell line. Ambrose JM; Veeraraghavan VP; Vennila R; Rupert S; Sathyanesan J; Meenakshisundaram R; Selvaraj S; Malayaperumal S; Kullappan M; Dorairaj S; Gujarathi JR; Gandhamaneni SH; Surapaneni KM J Egypt Natl Canc Inst; 2022 Dec; 34(1):51. PubMed ID: 36504339 [TBL] [Abstract][Full Text] [Related]
23. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling. Lamb R; Bonuccelli G; Ozsvári B; Peiris-Pagès M; Fiorillo M; Smith DL; Bevilacqua G; Mazzanti CM; McDonnell LA; Naccarato AG; Chiu M; Wynne L; Martinez-Outschoorn UE; Sotgia F; Lisanti MP Oncotarget; 2015 Oct; 6(31):30453-71. PubMed ID: 26421711 [TBL] [Abstract][Full Text] [Related]
24. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition. Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228 [TBL] [Abstract][Full Text] [Related]
25. HER2 overexpression-mediated inflammatory signaling enhances mammosphere formation through up-regulation of aryl hydrocarbon receptor transcription. Zhao S; Ohara S; Kanno Y; Midorikawa Y; Nakayama M; Makimura M; Park Y; Inouye Y Cancer Lett; 2013 Mar; 330(1):41-8. PubMed ID: 23196063 [TBL] [Abstract][Full Text] [Related]
26. Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. Dey D; Saxena M; Paranjape AN; Krishnan V; Giraddi R; Kumar MV; Mukherjee G; Rangarajan A PLoS One; 2009; 4(4):e5329. PubMed ID: 19390630 [TBL] [Abstract][Full Text] [Related]
27. Cellular communication promotes mammosphere growth and collective invasion through microtubule‑like structures and angiogenesis. Huang S; Yuan N; Wang G; Wu F; Feng L; Luo M; Li M; Luo A; Zhao X; Zhang L Oncol Rep; 2018 Dec; 40(6):3297-3312. PubMed ID: 30542711 [TBL] [Abstract][Full Text] [Related]
28. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094 [TBL] [Abstract][Full Text] [Related]
29. Mammosphere cells from high-passage MCF7 cell line show variable loss of tumorigenicity and radioresistance. Xie G; Zhan J; Tian Y; Liu Y; Chen Z; Ren C; Sun Q; Lian J; Chen L; Ruan J; Ye C; Sun A; Yuan Y Cancer Lett; 2012 Mar; 316(1):53-61. PubMed ID: 22108532 [TBL] [Abstract][Full Text] [Related]
30. Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties. Paranjape AN; Mandal T; Mukherjee G; Kumar MV; Sengupta K; Rangarajan A Oncogene; 2012 Apr; 31(15):1896-909. PubMed ID: 21874052 [TBL] [Abstract][Full Text] [Related]
31. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method. Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016 [TBL] [Abstract][Full Text] [Related]
32. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation. Glinka Y; Mohammed N; Subramaniam V; Jothy S; Prud'homme GJ Biochem Biophys Res Commun; 2012 Sep; 425(4):775-80. PubMed ID: 22885184 [TBL] [Abstract][Full Text] [Related]
33. Dynamic Phenotypic Transition of Breast Cancer Cells Oku Y; Nishiya N; Tsuda K; Shibazaki M; Maesawa C; Uehara Y Anticancer Res; 2017 Apr; 37(4):1793-1797. PubMed ID: 28373443 [TBL] [Abstract][Full Text] [Related]
34. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models. Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172 [TBL] [Abstract][Full Text] [Related]
35. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro]. Peng L; Li FX; Shao WF; Xiong JB Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739 [TBL] [Abstract][Full Text] [Related]
36. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells. Vazquez-Martin A; Oliveras-Ferraros C; Del Barco S; Martin-Castillo B; Menendez JA Breast Cancer Res Treat; 2011 Apr; 126(2):355-64. PubMed ID: 20458531 [TBL] [Abstract][Full Text] [Related]
37. Enrichment for breast cancer cells with stem/progenitor properties by differential adhesion. Walia V; Elble RC Stem Cells Dev; 2010 Aug; 19(8):1175-82. PubMed ID: 20222827 [TBL] [Abstract][Full Text] [Related]
38. Targeting tumor-initiating cells: eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction. Lamb R; Harrison H; Smith DL; Townsend PA; Jackson T; Ozsvari B; Martinez-Outschoorn UE; Pestell RG; Howell A; Lisanti MP; Sotgia F Oncotarget; 2015 Mar; 6(7):4585-601. PubMed ID: 25671304 [TBL] [Abstract][Full Text] [Related]
39. Micropatterning of neural stem cells and Purkinje neurons using a polydimethylsiloxane (PDMS) stencil. Choi JH; Lee H; Jin HK; Bae JS; Kim GM Lab Chip; 2012 Dec; 12(23):5045-50. PubMed ID: 23042549 [TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway. Yan XL; Fu CJ; Chen L; Qin JH; Zeng Q; Yuan HF; Nan X; Chen HX; Zhou JN; Lin YL; Zhang XM; Yu CZ; Yue W; Pei XT Breast Cancer Res Treat; 2012 Feb; 132(1):153-64. PubMed ID: 21584665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]